Skip to main content
    N

    Nu Skin Enterprises Inc (NUS)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $3.94
    -0.09 (-2.11%)

    Market Cap: $196.17M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Nu Skin Enterprises Inc (NUS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Nu Skin Enterprises (NUS) to earn $0.60 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.28B. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is $1.13.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 88.3% and revenue estimates rise 9.4%.

    Fiscal year ending Dec 31, 2026
    $0.60
    EPS consensus, revenue $1.28B
    Fiscal year ending Dec 31, 2027
    $1.13
    EPS consensus, revenue $1.40B
    Next report
    Feb 10, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.60$0.60 to $0.601$1.28B$1.28B to $1.28B1
    Dec 31, 2027$1.13$1.13 to $1.131$1.40B$1.40B to $1.40B1

    Quarterly Estimates

    The EPS consensus falls from $0.27 for the quarter ending Dec 31, 2026 to $0.16 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.27$0.26 to $0.282$350.98M$340.55M to $364.88M2
    Mar 31, 2027$0.16$0.16 to $0.161$328.70M$328.70M to $328.70M1

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202701
    Quarter ending Mar 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 40.0% from $1.00.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.60$0.82$0.82$0.82$1.00-40.0%
    Fiscal year ending Dec 31, 2027$1.13$1.16$1.16$1.16$1.32-14.4%
    Quarter ending Mar 31, 2027$0.16$0.19$0.19$0.19$0.23-30.4%

    Frequently Asked Questions About NUS

    What is the NUS stock forecast?

    Consensus analyst estimates put Nu Skin Enterprises's EPS at $0.60 for the fiscal year ending Dec 31, 2026, on revenue of $1.28B.

    What EPS do analysts expect from NUS next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.60, with estimates from $0.60 to $0.60 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.13, with estimates from $1.13 to $1.13 from 1 analyst.

    What revenue do analysts expect from Nu Skin Enterprises next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.28B, with estimates from $1.28B to $1.28B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.40B, with estimates from $1.40B to $1.40B.

    How many analysts cover NUS?

    1 analyst estimates EPS for Nu Skin Enterprises for the fiscal year ending Dec 31, 2026.